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Rome, ItalyVideothoracoscopic surgery has reduced the invasiveness of
a considerable number of thoracic operations, although op-
timal postoperative thoracic analgesia remains an open
issue.1 Among commonly used methods, continuous intra-
venous infusion of analgesics, including opioids and nonste-
roidal anti-inflammatory drugs, has shown promise but is not
always satisfactory and can have some adverse effects.2 We
developed a new technique of continuous intercostal-intra-
pleural analgesia (CIIA) in videothoracoscopic lung resec-
tions, which is based on a double-catheter pain relief
system (On-Q Pain Buster; I-Flow Corp, Lake Forest, Calif)
to provide continuous infusion of ropivacaine (Figure 1, A).
TECHNIQUE AND RESULTS
At the end of the operation, under thoracoscopic vision,
we place the first catheter just below the parietal pleura
and along the vascular-nervous intercostal bundle, which
crosses the passage of the chest tube; care is taken to push
the catheter as close as possible to the costovertebral junc-
tion (Figure 1, B). The second catheter is connected with
a double-lumen chest tube (26 F) to permit anesthetic release
from the tube’s extremity directly onto the pleuric dome
(Figure 1, A).
The 2 catheters are connected with the pump that allows
a continuous infusion of ropivacaine (2 mg/mL) at a flow
of 2 mL/h for each catheter (overall flow of 4 mL/h; Fig-
ure 2). Proper priming of the catheters is important as any
trapped air may impair the catheters’ performance; more-
over, intermittent aspiration of the catheter during placement
helps recognize incidental intravascular placement.
Between January and April 2006, a short pilot study was
carried out to test feasibility and efficacy of this method.
Eleven patients undergoing videothoracoscopic pulmonary
wedge resections received CIIA. A written informed consent
was obtained from all patients.
Primary outcome measures included technical feasibility,
assessment of thoracic pain according to the visual-analogue
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kin-6 plasma levels, additional analgesics needed, and dura-
tion of air leaks and hospital stay. Results were compared
with a similar control group undergoing continuous intrave-
nous analgesia (CIA) with tramadol and ketorolac during the
same period.
In the study group, technical feasibility was excellent in
10 patients and good in 1 due to the development of a limited
subpleural hematoma. There were no complications or col-
lateral adverse effects.
Intergroup comparisons (CIIA vs CIA) at 24 and 48 hours
showed a VAS of 2.3 0.9 versus 3.3 1.0 (P¼ .005) and
1.6  0.8 versus 2.1  0.6 (P ¼ .02), respectively, whereas
nursing-care calls were 3.4  0.8 versus 3.9  1.2 (P ¼ .2)
and 2.5  0.9 versus 3.4  0.8 (P ¼ .001), respectively. In-
terleukin-6 levels were 73 9 versus 82 10 (P¼ .01) and
38  11 versus 46  13 (P ¼ .06), respectively. Additional
analgesics within 48 hours were necessary in 3 versus 8 pa-
tients, respectively (P ¼ .04). Mean durations of air leaks
and hospital stay were 1.7  1.7 versus 2.6  2 (P ¼ .1)
and 2.5  1.5 versus 3.6  1.8 (P ¼ .04), respectively.
DISCUSSION
Morbidity in thoracic surgery can be affected by the effi-
cacy of postoperative pain management3 as impaired venti-
lation and coughing due to thoracic pain can trigger the
sequence of inadequate clearance of secretions–atelecta-
sis–pneumonia.
Currently, different methods are used for pain manage-
ment. Thoracic epidural analgesia is considered the gold
standard4 but may be somewhat oversized for many thoraco-
scopic procedures. As a result, the optimal analgesic regimen
for videothoracoscopic procedures is still debated. Continu-
ous infusion of nonsteroidal anti-inflammatory drugs is also
commonly used but may cause gastrointestinal problems and
bleeding. Opioids are often administered as a systemic anal-
gesic therapy but have collateral effects including respiratory
depression, nausea, vomiting, and constipation.
This new analgesic technique is aimed at treating the main
pain-triggering points in videothoracoscopic surgery, which
relates both to the intercostal space chosen for the chest tube
passage and the parietal pleura, which can be irritated by the
chest tube during lung expansion. We reasoned that by in-
hibiting pain at these 2 sites with long-acting local anes-
thetics, optimal thoracic analgesia could be achieved with
minor side effects. Moreover, placement of the cathetergery c January 2009
Brief CommunicationsFIGURE 1. Schematic illustration of the CIIA method showing the elastomeric pump (EP), the intercostal catheter (ICC), and the second elastomeric pump
catheter, connected to a double-lumen chest tube for high intrapleural release (IPR) of ropivacaine (A). Intraoperative thoracoscopic vision during transtho-
racic subpleural insertion of the intercostal catheter (ICC, black arrow) (B).beneath the parietal pleura under thoracoscopic vision re-
duces the risk of catheter dislocation, which has been re-
ported in up to 20% of patients.5 Finally, it is easy to
FIGURE 2. Immediate postoperative view showing the elastomeric pump
(EP), the intercostal catheter (ICC), and the double-lumen chest tube con-
nected to the pump for high intrapleural release (IPR) of ropivacaine.The Journal of Thoracic and Cplace the catheter close to the costovertebral junction, to
reach the posterior branch of the intercostal nerve that trans-
mits painful impulses from the posterior part of the intercos-
tal space.
We conclude that in patients having thoracoscopic lung
resection, CIIA proved easy, safe, and effective in ensuring
adequate thoracic analgesia. Moreover, comparison with
CIA results revealed that CIIA proved somewhat better in
terms of VAS, interleukin-6 production at 24 hours, nurs-
ing-care calls at 48 hours, and duration of hospitalization.
Further investigation is welcome to eventually confirm our
promising preliminary findings.
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